Cobalt Implantable Cardioverter Defibrillators with Cardiac Resynchronization Therapy (CRT-D)

FDA Device Recall #Z-1480-2022 — Class II — November 5, 2020

Recall Summary

Recall Number Z-1480-2022
Classification Class II — Moderate risk
Date Initiated November 5, 2020
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Location Mounds View, MN
Product Type Devices
Quantity 3 units

Product Description

Cobalt Implantable Cardioverter Defibrillators with Cardiac Resynchronization Therapy (CRT-D)

Reason for Recall

Manufacturing error that may have resulted in a cathode component being out of specification. All devices met final functional testing requirements.

Distribution Pattern

US Nationwide distribution in the states of Indiana and CA.

Lot / Code Information

GTIN 00763000178178, Serial Numbers: RTK601865S, RTK601825S, RTK601828S

Other Recalls from Medtronic Inc., Cardiac Rhythm and He...

Recall # Classification Product Date
Z-1707-2023 Class I ICD-DR DDBB2D1 EVERA XT IS1/DF1 INTL, Model Num... May 10, 2023
Z-1737-2023 Class I CRT-D DTBA2D4 VIVA XT IS1/DF4 INTL, Model Numbe... May 10, 2023
Z-1722-2023 Class I ICD DDPA2D1G COBALT XT DR MRI DF1 GOLD, Model N... May 10, 2023
Z-1746-2023 Class I CRT-D DTBB2D4 VIVA S IS1/DF4 INTL, Model Number... May 10, 2023
Z-1739-2023 Class I CRT-D DTBA2QQ VIVA QUAD XT IS4/DF4 INTL, Model ... May 10, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.